Dedong Cao

12PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersPhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 08, 2026
Predicting long-term survival following lung cancer resection based on early perioperative immune-metabolic response patterns.

|Sep 08, 2026
Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial.

|Jul 09, 2025
Efficacy and Safety of Second-Line Immune Checkpoint Inhibitor Rechallenge in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Wensi Zhao, Nan Zhao, Dedong Cao

|Dec 19, 2024
Analysis of the relationship between antineoplastic drugs and suicide-related adverse events based on the food and drug administration adverse event reporting system database.

Nan Zhao, Huimin Wang, Huilin Xu

|Jun 23, 2023
Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.

Xiaohong Liu, Dedong Cao, Hui Liu

|Jan 23, 2023
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis.

Huilin Xu, Dedong Cao, Dingjie Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Huilin Xu

2 joint publications

Xiaohong Liu

2 joint publications

Ximing Xu

1 joint publications

Tao Guo